Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Heidelberg Engineering Announces FDA Clearance for All-in-One ANTERION Platform

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Artivion Acquires Endospan for $135M Following...

US-based medical device company Artivion has completed its acquisition...

NHS Plans Single Patient Record to...

The National Health Service is moving forward with plans...

Embecta Completes £150m Acquisition of Owen...

Embecta has formally completed its acquisition of UK-based medical...

Heidelberg Engineering, a global leader in ophthalmic imaging and healthcare data solutions, announces FDA clearance of its innovative all-in-one ANTERION® platform, designed to transform anterior segment diagnostics and streamline practice workflow.

“Building upon our previous CE-marking, we are thrilled that the ANTERION platform is now available to eye care providers across the U.S.,” said Arianna Schoess Vargas, Managing Director of Heidelberg Engineering GmbH. “We believe this device complements our current portfolio of products and arms anterior segment focused practices with the comprehensive data needed to support diagnostic decisions that ultimately improve patient care.”

As an all-in-one upgradeable platform, ANTERION combines biometry, IOL power calculation with corneal topography and tomography, anterior chamber metrics, and high-resolution imaging to help revolutionize the day-to-day clinical routine. Additional proprietary features such as patented eye tracking and composite imaging technologies help deliver exceptional Heidelberg image quality, allowing eye care professionals to perform anterior segment examinations and acquire key measurements via high-resolution swept-source OCT images that support clinical decision-making and increase diagnostic confidence.

Mitchell W. Dul, OD, MS, Principal Investigator of the clinical trial, said, “We were impressed by the high-quality images and measurements of the anterior segment that ANTERION offers. Its multi-faceted utility, high resolution, rapid image acquisition, and intuitive user interface will make this device an invaluable tool for clinical practice.”

Central to the ANTERION platform is the Imaging App, which was FDA cleared in November 2021. The Imaging App focuses on the high-resolution visualization of the anterior segment and delivers impressive and revealing OCT images that assist eye doctors in the diagnosis and management of anterior segment alterations. ANTERION’s functionality has been expanded with the newly FDA cleared apps designed to meet a variety of clinical needs:

  • The Cataract App combines key measurements for cataract surgery planning, including integrated monofocal and toric IOL calculators. The ability to assess corneal wavefront and total power supports a more suitable IOL selection and helps avoid refractive surprises even in challenging eyes.
  • The Cornea App provides a comprehensive set of corneal measurements for the evaluation of a patient’s individual corneal geometry. These diagnostic insights can be used to help support the surgical planning and evaluation of refractive procedures.
  • The Metrics App features swept-source OCT images with the anterior chamber displayed in a radial view. Predefined angle parameters can be determined, and free-hand measurements can also be performed.

Never miss a healthcare headline

Healthcare moves fast – stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management
MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Artivion Acquires Endospan for $135M Following FDA Approval of NEXUS Aortic Graft Stent System

US-based medical device company Artivion has completed its acquisition...

NHS Plans Single Patient Record to Transform Healthcare

The National Health Service is moving forward with plans...

Ooredoo Kuwait and Hadi Clinic Announce Strategic Digital Transformation Partnership

Ooredoo Kuwait and Hadi Clinic have officially entered into...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »